IMLFF News and Press, InMed Pharmaceuticals Inc. From 01/08/21

InMed Announces Results of Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects PR Newswire TSX: IN NASDAQ: INM VANCOUVER, BC , Jan. 8, 2021 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: I...

InMed to Participate at Virtual Conferences in January 2021 Canada NewsWire VANCOUVER, BC , Jan. 5, 2021 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage pharmaceutical company developing medications targ...

2020 saw increases of 80% in Canada and expectations are for that to double next year. California will lead revenue growth rates as the state continues to ramp up the industry. Washington and Colorado are starting to see overall growth rates slow modestly, excepting pandemic-induc...

Several mergers have been announced over the past few days and this has driven cannabis stocks upwards. A newer industry is still seeing tremendous growth rates in QoQ revenues. Keeping an eye on the fastest growing revenue stocks may be key to increasing profits in investments. ...

InMed Licenses MiDROPS® Delivery Technology from EyeCRO for the Delivery of Therapeutic Cannabinoids TSX:IN NASDAQ:INM - Initial application with INM-088 to treat ocular disease - VANCOUVER, BC , Dec. 3, 2020 /CNW/ - InMed Pharmaceuticals Inc. ...

InMed Announces Results of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects Canada NewsWire VANCOUVER, BC, Nov. 25, 2020 VANCOUVER, BC , Nov. 25, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX:...

InMed Pharmaceuticals and BayMedica Announce Collaboration for Manufacturing and Testing of Novel Cannabinoid Therapeutics PR Newswire VANCOUVER, BC, Nov. 18, 2020 VANCOUVER, BC , Nov. 18, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Co...

InMed Pharmaceuticals Announces the Closing of US$8 Million Public Offering PR Newswire VANCOUVER, BC, Nov. 16, 2020 VANCOUVER, BC , Nov. 16, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-st...

InMed Announces Pricing of US$8M Public Offering and Listing on the Nasdaq Capital Market Under the Symbol "INM" Canada NewsWire VANCOUVER, BC, Nov. 12, 2020 VANCOUVER, BC , Nov. 12, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASD...

InMed Reschedules Reporting of First Quarter Financial Results and Business Update to November 13, 2020 PR Newswire VANCOUVER, BC, Nov. 5, 2020 VANCOUVER, BC , Nov. 5, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OT...